Nan Fung Group Holdings as of Dec. 31, 2023
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 39 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 44.5 | $71M | 226k | 316.51 | |
| Illumina (ILMN) | 10.3 | $17M | 119k | 139.24 | |
| Harmony Biosciences Hldgs In (HRMY) | 7.4 | $12M | 369k | 32.30 | |
| Oculis Holding Ordinary Shares (OCS) | 3.6 | $5.8M | 519k | 11.23 | |
| Exscientia Ads (EXAI) | 3.4 | $5.5M | 860k | 6.41 | |
| Alpine Immune Sciences | 3.1 | $5.0M | 264k | 19.06 | |
| Xenon Pharmaceuticals (XENE) | 3.1 | $4.9M | 107k | 46.06 | |
| Somalogic Class A Com | 2.7 | $4.3M | 1.7M | 2.53 | |
| Merus N V (MRUS) | 2.3 | $3.8M | 137k | 27.50 | |
| Kalvista Pharmaceuticals (KALV) | 2.3 | $3.7M | 304k | 12.25 | |
| Mirum Pharmaceuticals (MIRM) | 1.8 | $2.8M | 96k | 29.52 | |
| Pacific Biosciences of California (PACB) | 1.7 | $2.7M | 275k | 9.81 | |
| Beigene Sponsored Adr (BGNE) | 1.4 | $2.2M | 12k | 180.36 | |
| Incyte Corporation (INCY) | 1.3 | $2.0M | 32k | 62.79 | |
| Geron Corporation (GERN) | 1.2 | $1.9M | 914k | 2.11 | |
| Rhythm Pharmaceuticals (RYTM) | 1.1 | $1.8M | 40k | 45.97 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 1.0 | $1.6M | 494k | 3.32 | |
| Replimune Group (REPL) | 1.0 | $1.6M | 185k | 8.43 | |
| Exelixis (EXEL) | 1.0 | $1.5M | 64k | 23.99 | |
| Bolt Biotherapeutics (BOLT) | 0.8 | $1.3M | 1.2M | 1.12 | |
| Aerovate Therapeutics (AVTE) | 0.7 | $1.1M | 48k | 22.63 | |
| Cabaletta Bio (CABA) | 0.7 | $1.1M | 47k | 22.70 | |
| ACADIA Pharmaceuticals (ACAD) | 0.6 | $939k | 30k | 31.31 | |
| Entrada Therapeutics (TRDA) | 0.5 | $741k | 49k | 15.09 | |
| Alx Oncology Hldgs (ALXO) | 0.4 | $625k | 42k | 14.89 | |
| Biomea Fusion (BMEA) | 0.4 | $581k | 40k | 14.52 | |
| Argenx Se Sponsored Adr (ARGX) | 0.3 | $544k | 1.4k | 380.43 | |
| Athira Pharma (ATHA) | 0.3 | $437k | 180k | 2.43 | |
| Eargo Com New | 0.2 | $383k | 148k | 2.59 | |
| Dbv Technologies S A Sponsored Adr | 0.2 | $353k | 371k | 0.95 | |
| BioMarin Pharmaceutical (BMRN) | 0.2 | $349k | 3.6k | 96.42 | |
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $274k | 1.2k | 231.38 | |
| Affimed Therapeutics B V | 0.1 | $233k | 373k | 0.62 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $107k | 18k | 5.99 | |
| Galera Therapeutics (GRTX) | 0.1 | $89k | 613k | 0.15 | |
| Abcellera Biologics (ABCL) | 0.0 | $72k | 13k | 5.71 | |
| Kodiak Sciences (KOD) | 0.0 | $60k | 20k | 3.04 | |
| Fibrogen (FGEN) | 0.0 | $55k | 62k | 0.89 | |
| Cerus Corporation (CERS) | 0.0 | $31k | 14k | 2.16 |
